Jacinth Joseph

402 total citations
16 papers, 179 citations indexed

About

Jacinth Joseph is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Jacinth Joseph has authored 16 papers receiving a total of 179 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Genetics and 5 papers in Oncology. Recurrent topics in Jacinth Joseph's work include CAR-T cell therapy research (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Jacinth Joseph is often cited by papers focused on CAR-T cell therapy research (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Jacinth Joseph collaborates with scholars based in United States, United Kingdom and Cyprus. Jacinth Joseph's co-authors include Christin B. DeStefano, Liem Phan, Damiano Rondelli, Santosh L. Saraf, Gregory M.T. Guilcher, Tony H. Truong, Matthew M. Hsieh, Courtney D. Fitzhugh, Allistair Abraham and Rachel Hicklen and has published in prestigious journals such as Blood, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Jacinth Joseph

14 papers receiving 177 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacinth Joseph United States	6	65	64	60	52	42	16	179
Verena Wais Germany	8	48 0.7×	55 0.9×	51 0.8×	46 0.9×	8 0.2×	21	193
Jadee Neff United States	7	29 0.4×	24 0.4×	34 0.6×	48 0.9×	13 0.3×	25	159
Rita Maria Pinto Italy	10	36 0.6×	153 2.4×	100 1.7×	46 0.9×	76 1.8×	19	291
Carolyn Mulroney United States	8	78 1.2×	34 0.5×	24 0.4×	35 0.7×	33 0.8×	29	210
Joseph H. Oved United States	8	48 0.7×	71 1.1×	24 0.4×	33 0.6×	6 0.1×	34	185
Cristina Verzeroli Italy	6	24 0.4×	39 0.6×	17 0.3×	47 0.9×	6 0.1×	16	179
Stephanie Sontag Germany	9	36 0.6×	32 0.5×	46 0.8×	184 3.5×	18 0.4×	14	276
Marie Hélène Delfau France	7	17 0.3×	120 1.9×	81 1.4×	175 3.4×	44 1.0×	12	308
Olga Grishina Germany	7	46 0.7×	161 2.5×	60 1.0×	53 1.0×	11 0.3×	16	269
Jianmin Wang China	9	20 0.3×	79 1.2×	49 0.8×	73 1.4×	30 0.7×	17	326

Countries citing papers authored by Jacinth Joseph

Since Specialization

Citations

This map shows the geographic impact of Jacinth Joseph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacinth Joseph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacinth Joseph more than expected).

Fields of papers citing papers by Jacinth Joseph

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacinth Joseph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacinth Joseph. The network helps show where Jacinth Joseph may publish in the future.

Co-authorship network of co-authors of Jacinth Joseph

This figure shows the co-authorship network connecting the top 25 collaborators of Jacinth Joseph. A scholar is included among the top collaborators of Jacinth Joseph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacinth Joseph. Jacinth Joseph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Chandra, Prem, Hana J Abukhadijah, Tawa Olukade, et al.. (2025). Impact of pregnant mothers’ previous COVID-19 infection and vaccination on newborns’ serological profiling. Frontiers in Immunology. 16. 1526264–1526264.

Joseph, Jacinth, Samer A. Srour, Denái R. Milton, et al.. (2023). Transplantation Outcomes of Myelofibrosis with Busulfan and Fludarabine Myeloablative Conditioning. Transplantation and Cellular Therapy. 29(12). 770.e1–770.e6. 3 indexed citations

Joseph, Jacinth, et al.. (2022). CAR T-Cell Therapy for Patients with Multiple Myeloma: Current Evidence and Challenges. PubMed. Volume 12. 119–136. 41 indexed citations

Joseph, Jacinth, et al.. (2022). 233 A real-world case of second chimeric antigen receptor t-cell therapy. Regular and Young Investigator Award Abstracts. A247–A247.

Kamal, Mona, Jacinth Joseph, Uri Greenbaum, et al.. (2021). Patient-Reported Outcomes for Cancer Patients with Hematological Malignancies Undergoing Chimeric Antigen Receptor T Cell Therapy: A Systematic Review. Transplantation and Cellular Therapy. 27(5). 390.e1–390.e7. 28 indexed citations

Joseph, Jacinth & Uday Popat. (2020). A Mildly Symptomatic Middle-Aged Woman with INT-1 Primary Myelofibrosis. Clinical Lymphoma Myeloma & Leukemia. 20. S19–S19. 1 indexed citations

Joseph, Jacinth, Arun Rajan, James L. Gulley, Sawa Ito, & Craig M. Kessler. (2020). Acquired Coagulopathy With Immune Checkpoint Inhibitors: An Underrecognized Association Between Inflammation and Coagulation. JTO Clinical and Research Reports. 1(3). 100049–100049. 5 indexed citations

Joseph, Jacinth, et al.. (2020). Fresh Versus Cryopreserved Peripheral Stem Cell for Autologous Transplantation in Multiple Myeloma: An Analysis of Short-Term Outcomes. Blood. 136(Supplement 1). 9–10. 2 indexed citations

Joseph, Jacinth, Denái R. Milton, Gheath Alatrash, et al.. (2020). MPN-188: Myeloablative Fludarabine and Busulfan Regimen in Myelofibrosis (MF): Long-Term Outcomes and Analysis of Prognostic Factors. Clinical Lymphoma Myeloma & Leukemia. 20. S333–S333. 1 indexed citations

10.

Guilcher, Gregory M.T., Tony H. Truong, Santosh L. Saraf, et al.. (2018). Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease. Seminars in Hematology. 55(2). 87–93. 47 indexed citations

11.

Joseph, Jacinth, Allistair Abraham, & Courtney D. Fitzhugh. (2018). When there is no match, the game is not over: Alternative donor options for hematopoietic stem cell transplantation in sickle cell disease. Seminars in Hematology. 55(2). 94–101. 16 indexed citations

12.

Vakiti, Anusha, et al.. (2018). Ifosfamide-Induced Metabolic Encephalopathy in 2 Patients With Cutaneous T-Cell Lymphoma Successfully Treated With Methylene Blue. Journal of Investigative Medicine High Impact Case Reports. 6. 2735251921–2735251921. 10 indexed citations

13.

Kerr, Gail S., et al.. (2018). FRI0236 Associations between comorbidity and urate deposition in subjects with asymptomatic hyperuricemia: a pilot study. Annals of the Rheumatic Diseases. 77. 659–659. 1 indexed citations

14.

Joseph, Jacinth, et al.. (2018). AB0277 Leptin and adiponectin levels in rheumatoid arthritis patients. Annals of the Rheumatic Diseases. 77. 1318–1318. 1 indexed citations

15.

Kyriakides, Theodoros, C. Angelini, J. Schaefer, et al.. (2013). EFNS review on the role of muscle biopsy in the investigation of myalgia. European Journal of Neurology. 20(7). 997–1005. 22 indexed citations

16.

Moulin, G, et al.. (1981). [Cefotaxime in the treatment of genital gonorrhea].. PubMed. 107(8-9). 833–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact